Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1989;9:319-325

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auwerx, J. H.
Right arrow Articles by Brunzell, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auwerx, J. H.
Right arrow Articles by Brunzell, J. D.

Arteriosclerosis, Vol 9, 319-325, Copyright © 1989 by American Heart Association


ARTICLES

Large buoyant LDL-like particles in hepatic lipase deficiency

JH Auwerx, CA Marzetta, JE Hokanson and JD Brunzell
Department of Medicine, University of Washington, Seattle 98195.

Hepatic lipase (HL) is thought to play a role in processing very low density lipoprotein to low density lipoprotein (LDL). To analyze the relationship between HL and LDL, the density, size, and chemical composition of LDL isolated from 18 normal subjects and from three subjects with reduced or absent levels of HL activity were compared. In an HL-deficient subject, the major peak of apoprotein (apo) B- containing lipoproteins ('LDL') had a density of 1.023 g/ml and a diameter of 26.4 nm compared to male control subjects (1.044 +/- 0.006 g/ml and 25.3 +/- 0.3 nm). Two half-sisters of the HL-deficient subject with half the normal levels of HL activity had LDL that also were more buoyant and slightly larger than the LDL isolated from female control subjects. The peak density and average diameter of LDL were correlated with HL activity, consistent with the hypothesis that HL influenced formation and physical characteristics of typical LDL. Apo B-100 was the major apoprotein in the 'LDL' isolated from the HL-deficient subject and contained a greater proportion of triglyceride compared to the control subjects' LDL. The absence of HL appears to prevent the production of classical LDL. Our data support the hypothesis that HL helps determine normal LDL characteristics.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
E. K. Young, C. Chatterjee, and D. L. Sparks
HDL-ApoE Content Regulates the Displacement of Hepatic Lipase from Cell Surface Proteoglycans
Am. J. Pathol., July 1, 2009; 175(1): 448 - 457.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. C. Crawford, A. S. Nord, M. D. Badzioch, J. Ranchalis, L. A. McKinstry, M. Ahearn, C. Bertucci, C. Shephard, M. Wong, M. J. Rieder, et al.
A common VLDLR polymorphism interacts with APOE genotype in the prediction of carotid artery disease risk
J. Lipid Res., March 1, 2008; 49(3): 588 - 596.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. J. Albers, S. M. Marcovina, G. Imperatore, B. M. Snively, J. Stafford, W. Y. Fujimoto, E. J. Mayer-Davis, D. B. Petitti, C. Pihoker, L. Dolan, et al.
Prevalence and Determinants of Elevated Apolipoprotein B and Dense Low-Density Lipoprotein in Youths with Type 1 and Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 735 - 742.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Q. Purnell, L. B. Bland, M. Garzotto, D. Lemmon, E. M. Wersinger, C. W. Ryan, J. D. Brunzell, and T. M. Beer
Effects of transdermal estrogen on levels of lipids, lipase activity, and inflammatory markers in men with prostate cancer
J. Lipid Res., February 1, 2006; 47(2): 349 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. S. Rozek, T. S. Hatsukami, R. J. Richter, J. Ranchalis, K. Nakayama, L. A. McKinstry, D. A. Gortner, E. Boyko, G. D. Schellenberg, C. E. Furlong, et al.
The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status
J. Lipid Res., September 1, 2005; 46(9): 1888 - 1895.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
U. C. Broedl, C. Maugeais, J. S. Millar, W. Jin, R. E. Moore, I. V. Fuki, D. Marchadier, J. M. Glick, and D. J. Rader
Endothelial Lipase Promotes the Catabolism of ApoB-Containing Lipoproteins
Circ. Res., June 25, 2004; 94(12): 1554 - 1561.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. L. Dichek, K. Qian, and N. Agrawal
The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient "apoB-48-only" and "apoB-100-only" mice
J. Lipid Res., March 1, 2004; 45(3): 551 - 560.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Rizzo, J. M. Taylor, C. M. Barbagallo, K. Berneis, P. J. Blanche, and R. M. Krauss
Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits
Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 141 - 146.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Q. Purnell, D. S. Weigle, P. Breen, and D. E. Cummings
Ghrelin Levels Correlate with Insulin Levels, Insulin Resistance, and High-Density Lipoprotein Cholesterol, But Not with Gender, Menopausal Status, or Cortisol Levels in Humans
J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5747 - 5752.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. E. Hokanson, M. I. Kamboh, S. Scarboro, R. H. Eckel, and R. F. Hamman
Effects of the Hepatic Lipase Gene and Physical Activity on Coronary Heart Disease Risk
Am. J. Epidemiol., November 1, 2003; 158(9): 836 - 843.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
I. L. Ruel, P. Couture, C. Gagne, Y. Deshaies, J. Simard, R. A. Hegele, and B. Lamarche
Characterization of a novel mutation causing hepatic lipase deficiency among French Canadians
J. Lipid Res., August 1, 2003; 44(8): 1508 - 1514.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. D. Sibley, J. P. Palmer, I. B. Hirsch, and J. D. Brunzell
Visceral Obesity, Hepatic Lipase Activity, and Dyslipidemia in Type 1 Diabetes
J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3379 - 3384.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. S. Deeb, A. Zambon, M. C. Carr, A. F. Ayyobi, and J. D. Brunzell
Hepatic lipase and dyslipidemia: interactions among genetic variants, obesity, gender, and diet
J. Lipid Res., July 1, 2003; 44(7): 1279 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. L. Herbst, J. K. Amory, J. D. Brunzell, H. A. Chansky, and W. J. Bremner
Testosterone administration to men increases hepatic lipase activity and decreases HDL and LDL size in 3 wk
Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1112 - E1118.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. K. Berneis and R. M. Krauss
Metabolic origins and clinical significance of LDL heterogeneity
J. Lipid Res., September 1, 2002; 43(9): 1363 - 1379.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. W. Skeggs and R. E. Morton
LDL and HDL enriched in triglyceride promote abnormal cholesterol transport
J. Lipid Res., August 1, 2002; 43(8): 1264 - 1274.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. C. Carr, J. E. Hokanson, A. Zambon, S. S. Deeb, P. H. R. Barrett, J. Q. Purnell, and J. D. Brunzell
The Contribution of Intraabdominal Fat to Gender Differences in Hepatic Lipase Activity and Low/High Density Lipoprotein Heterogeneity
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2831 - 2837.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. L. Dichek, S. M. Johnson, H. Akeefe, G. T. Lo, E. Sage, C. E. Yap, and R. W. Mahley
Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice
J. Lipid Res., February 1, 2001; 42(2): 201 - 210.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
A. Zambon, S. S. Deeb, A. Bensadoun, K. E. Foster, and J. D. Brunzell
In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity
J. Lipid Res., December 1, 2000; 41(12): 2094 - 2099.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Winkler, B. Wetzka, M. M. Hoffmann, I. Friedrich, M. Kinner, M. W. Baumstark, H. Wieland, W. März, and H. P. Zahradnik
Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4543 - 4550.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
B. M. Schamberger, H. C. Geiss, M. M. Ritter, P. Schwandt, and K. G. Parhofer
Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia
J. Lipid Res., May 1, 2000; 41(5): 727 - 733.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Q. Purnell, S. E. Kahn, J. J. Albers, D. N. Nevin, J. D. Brunzell, and R. S. Schwartz
Effect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 977 - 982.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
H. Allayee, K. M. Dominguez, B. E. Aouizerat, R. M. Krauss, J. I. Rotter, J. Lu, R. M. Cantor, T. W. A. de Bruin, and A. J. Lusis
Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia
J. Lipid Res., February 1, 2000; 41(2): 245 - 252.
[Abstract] [Full Text]


Home page
CirculationHome page
A. Zambon, J. E. Hokanson, B. G. Brown, and J. D. Brunzell
Evidence for a New Pathophysiological Mechanism for Coronary Artery Disease Regression : Hepatic Lipase–Mediated Changes in LDL Density
Circulation, April 20, 1999; 99(15): 1959 - 1964.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. J. A. Amar, K. A. Dugi, C. C. Haudenschild, R. D. Shamburek, B. Foger, M. Chase, A. Bensadoun, R. F. Hoyt , Jr., H. B. Brewer , Jr., and S. Santamarina-Fojo
Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice
J. Lipid Res., December 1, 1998; 39(12): 2436 - 2442.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
S. Qiu, N. Bergeron, L. Kotite, R. M. Krauss, A. Bensadoun, and R. J. Havel
Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice
J. Lipid Res., August 1, 1998; 39(8): 1661 - 1668.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. L. Dichek, W. Brecht, J. Fan, Z.-S. Ji, S. P. A. McCormick, H. Akeefe, L. Conzo, D. A. Sanan, K. H. Weisgraber, S. G. Young, et al.
Overexpression of Hepatic Lipase in Transgenic Mice Decreases Apolipoprotein B-containing and High Density Lipoproteins. EVIDENCE THAT HEPATIC LIPASE ACTS AS A LIGAND FOR LIPOPROTEIN UPTAKE
J. Biol. Chem., January 23, 1998; 273(4): 1896 - 1903.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. J. Packard and J. Shepherd
Lipoprotein Heterogeneity and Apolipoprotein B Metabolism
Arterioscler Thromb Vasc Biol, December 1, 1997; 17(12): 3542 - 3556.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. S. Moran, J. H. Campbell, and G. R. Campbell
Human Leukemia Inhibitory Factor Upregulates LDL Receptors on Liver Cells and Decreases Serum Cholesterol in the Cholesterol-Fed Rabbit
Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1267 - 1273.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. T. Williams and R. M. Krauss
Associations of Age, Adiposity, Menopause, and Alcohol Intake With Low-Density Lipoprotein Subclasses
Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1082 - 1090.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
L. K. Kwong, D. N. Ridinger, M. Bandhauer, J. H. Ward, W. E. Samlowski, P.-H. Iverius, H. Pritchard, and D. E. Wilson
Acute Dyslipoproteinemia Induced by Interleukin-2: Lecithin:Cholesteryl Acyltransferase, Lipoprotein Lipase, and Hepatic Lipase Deficiencies
J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1572 - 1581.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
C. D. Gardner, S. P. Fortmann, and R. M. Krauss
Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women
JAMA, September 18, 1996; 276(11): 875 - 881.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. H. Capell, A. Zambon, M. A. Austin, J. D. Brunzell, and J. E. Hokanson
Compositional Differences of LDL Particles in Normal Subjects With LDL Subclass Phenotype A and LDL Subclass Phenotype B
Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 1040 - 1046.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H.-O. Mowri, J. R. Patsch, A. M. Gotto Jr, and W. Patsch
Apolipoprotein A-II Influences the Substrate Properties of Human HDL2 and HDL3 for Hepatic Lipase
Arterioscler Thromb Vasc Biol, June 1, 1996; 16(6): 755 - 762.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K.-i. Hirano, S. Yamashita, Y. Kuga, N. Sakai, S. Nozaki, S. Kihara, T. Arai, K. Yanagi, S. Takami, M. Menju, et al.
Atherosclerotic Disease in Marked Hyperalphalipoproteinemia : Combined Reduction of Cholesteryl Ester Transfer Protein and Hepatic Triglyceride Lipase
Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1849 - 1856.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
K. A. Dugi, H.én L. Dichek, and S. Santamarina-Fojo
Human Hepatic and Lipoprotein Lipase: The Loop Covering the Catalytic Site Mediates Lipase Substrate Specificity
J. Biol. Chem., October 27, 1995; 270(43): 25396 - 25401.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Tilly-Kiesi, Z. Qiuping, S. Ehnholm, J. Kahri, S. Lahdenpera, C. Ehnholm, and M.-R. Taskinen
ApoA-IHelsinki (Lys107->0) Associated With Reduced HDL Cholesterol and LpA-I:A-II Deficiency
Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1294 - 1306.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
B. L. Vaisman, H.-G. Klein, M. Rouis, A. M. Bérard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. HoytJr., S. M. Marcovina, J. J. Albers, et al.
Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice
J. Biol. Chem., May 19, 1995; 270(20): 12269 - 12275.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Homanics, H. V. de Silva, J.ús Osada, S. H. Zhang, H. Wong, J. Borensztajn, and N. Maeda
Mild Dyslipidemia in Mice following Targeted Inactivation of the Hepatic Lipase Gene
J. Biol. Chem., February 17, 1995; 270(7): 2974 - 2980.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. H. Slyper
Low-Density Lipoprotein Density and Atherosclerosis: Unraveling the Connection
JAMA, July 27, 1994; 272(4): 305 - 308.
[Abstract] [PDF]